Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3- a :3',4'- c ]quinoxaline derivatives as anticancer agents and apoptosis inducers.

MLA

Alsaif, Nawaf A., et al. “Discovery of New VEGFR-2 Inhibitors Based on Bis([1, 2, 4]Triazolo)[4,3- a :3’,4’- c ]Quinoxaline Derivatives as Anticancer Agents and Apoptosis Inducers.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 36, no. 1, Dec. 2021, pp. 1093–114. EBSCOhost, https://doi.org/10.1080/14756366.2021.1915303.

APA

Alsaif, N. A., Taghour, M. S., Alanazi, M. M., Obaidullah, A. J., Al-Mehizia, A. A., Alanazi, M. M., Aldawas, S., Elwan, A., & Elkady, H. (2021). Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3- a :3’,4’- c ]quinoxaline derivatives as anticancer agents and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 1093–1114. https://doi.org/10.1080/14756366.2021.1915303

Chicago

Alsaif, Nawaf A, Mohammed S Taghour, Mohammed M Alanazi, Ahmad J Obaidullah, Abdulrahman A Al-Mehizia, Manal M Alanazi, Saleh Aldawas, Alaa Elwan, and Hazem Elkady. 2021. “Discovery of New VEGFR-2 Inhibitors Based on Bis([1, 2, 4]Triazolo)[4,3- a :3’,4’- c ]Quinoxaline Derivatives as Anticancer Agents and Apoptosis Inducers.” Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1): 1093–1114. doi:10.1080/14756366.2021.1915303.